Harleen Chela

419 total citations · 1 hit paper
53 papers, 217 citations indexed

About

Harleen Chela is a scholar working on Surgery, Epidemiology and Oncology. According to data from OpenAlex, Harleen Chela has authored 53 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 16 papers in Epidemiology and 14 papers in Oncology. Recurrent topics in Harleen Chela's work include Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (8 papers) and Gastrointestinal disorders and treatments (7 papers). Harleen Chela is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (8 papers) and Gastrointestinal disorders and treatments (7 papers). Harleen Chela collaborates with scholars based in United States and Pakistan. Harleen Chela's co-authors include Ebubekir Daglilar, Veysel Tahan, Francis Dailey, Fatiha Nassir, Karthik Gangu, Omar Elfeky, S. Hasan Naqvi, Umer Farooq, Nisar A. Amin and Archana Vasudevan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Gastroenterology and Medicine.

In The Last Decade

Harleen Chela

41 papers receiving 213 citations

Hit Papers

Pancreatitis Risk Associated with GLP-1 Receptor Agonists... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harleen Chela United States 8 83 61 46 38 30 53 217
Hun Jee Choe South Korea 7 41 0.5× 47 0.8× 86 1.9× 11 0.3× 16 0.5× 26 236
Mazin Khalid United States 9 60 0.7× 98 1.6× 42 0.9× 23 0.6× 27 0.9× 45 270
Dawn R. Ebach United States 7 100 1.2× 105 1.7× 23 0.5× 14 0.4× 35 1.2× 11 306
Shon Meek United States 10 147 1.8× 114 1.9× 201 4.4× 28 0.7× 15 0.5× 21 422
Marinos C. Makris Greece 9 146 1.8× 59 1.0× 12 0.3× 71 1.9× 96 3.2× 21 327
Intan Nureslyna Samsudin Malaysia 6 74 0.9× 108 1.8× 39 0.8× 20 0.5× 16 0.5× 34 277
Bruna Ramos da Silva Brazil 10 29 0.3× 24 0.4× 32 0.7× 33 0.9× 11 0.4× 31 352
А. В. Охлобыстин Russia 9 118 1.4× 68 1.1× 28 0.6× 81 2.1× 39 1.3× 23 274
Т. Л. Лапина Russia 12 325 3.9× 58 1.0× 15 0.3× 25 0.7× 83 2.8× 44 538
Mark Reinhard Denmark 9 163 2.0× 59 1.0× 85 1.8× 24 0.6× 22 0.7× 25 376

Countries citing papers authored by Harleen Chela

Since Specialization
Citations

This map shows the geographic impact of Harleen Chela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harleen Chela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harleen Chela more than expected).

Fields of papers citing papers by Harleen Chela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harleen Chela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harleen Chela. The network helps show where Harleen Chela may publish in the future.

Co-authorship network of co-authors of Harleen Chela

This figure shows the co-authorship network connecting the top 25 collaborators of Harleen Chela. A scholar is included among the top collaborators of Harleen Chela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harleen Chela. Harleen Chela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chela, Harleen, et al.. (2025). Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis. Journal of Clinical Medicine. 14(3). 944–944. 16 indexed citations breakdown →
2.
Amin, Nisar A., et al.. (2025). Outcomes of Outpatient Elective Esophageal Varices Band Ligation in Cirrhosis Patients with Significant Thrombocytopenia. Diseases. 13(2). 27–27. 2 indexed citations
3.
Amin, Nisar A., et al.. (2025). Uncommon metastatic pattern of renal cell carcinoma (simultaneous metastasis to the small intestine and skeletal muscle): A case report. World Journal of Gastrointestinal Pharmacology and Therapeutics. 16(3). 108266–108266.
4.
Anwar, Nadeem, et al.. (2024). SARS-CoV-2 Infection Is an Independent Risk Factor for Decompensation in Cirrhosis Patients. SHILAP Revista de lepidopterología. 12(3). 46–46. 4 indexed citations
5.
Chela, Harleen, et al.. (2024). Isolated Terminal Ileitis- Crohn’s Disease or Something Else?. 10(13). 1–6.
7.
Anwar, Nadeem, et al.. (2024). Outpatient use of antibiotics in uncomplicated diverticulitis decreases hospital admissions. Immunity Inflammation and Disease. 12(9). e70031–e70031.
8.
9.
Chela, Harleen, et al.. (2023). Gardner syndrome: a mini review. 1(1).
10.
Elfeky, Omar, et al.. (2023). Scurvy: Rediscovering a Forgotten Disease. SHILAP Revista de lepidopterología. 11(2). 78–78. 31 indexed citations
11.
Barffour, Maxwell A., et al.. (2023). S1185 Disease Localization and Use of Proton Pump Inhibitors as Predictors of Serum Cobalamin and Vitamin D Status in Patients With Inflammatory Bowel Disease. The American Journal of Gastroenterology. 118(10S). S906–S906. 1 indexed citations
13.
Chela, Harleen, et al.. (2022). Non-Alcoholic Fatty Pancreas Disease: The Unsung Disease. Endocrine Metabolic & Immune Disorders - Drug Targets. 23(4). 485–493. 2 indexed citations
14.
Gangu, Karthik, et al.. (2022). Trends of Cocaine Use and Manifestations in Hospitalized Patients: A Cross-Sectional Study. Cureus. 14(2). e22090–e22090. 10 indexed citations
15.
Chela, Harleen, et al.. (2020). Stem cell therapy: a potential for the perils of pancreatitis. The Turkish Journal of Gastroenterology. 31(6). 415–424. 3 indexed citations
16.
Chela, Harleen, et al.. (2020). Liver in the limelight in the corona (COVID-19) time. World Journal of Clinical Cases. 8(16). 3405–3410. 2 indexed citations
17.
Chela, Harleen, et al.. (2019). Adrenocorticotropic Hormone-producing Extrapulmonary Small Cell Carcinoma of the Breast. Cureus. 11(12). e6488–e6488. 2 indexed citations
18.
Chela, Harleen, et al.. (2017). Elderly donor graft for liver transplantation: Never too late. World Journal of Transplantation. 7(6). 324–328. 1 indexed citations
19.
Chela, Harleen, et al.. (2016). Pancreatic Cancer Survival Outcomes at a Tertiary Medical Center Based on Sex and Geographic Location. Southern Medical Journal. 109(11). 718–720. 3 indexed citations
20.
Chela, Harleen, et al.. (2015). Pseudomelanosis Duodeni. ACG Case Reports Journal. 2(1). 72–73. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026